Gene content    
FGFR1 ( by HUGO)
Fibroblast Growth Factor Receptor 1
Oncogene
Fibroblast Growth Factor Receptor 1
FLT2
KAL2
Fms-Related Tyrosine Kinase 2
Basic Fibroblast Growth Factor Receptor 1
Fms-Like Tyrosine Kinase 2
Proto-Oncogene C-Fgr
BFGFR
CEK
FGFBR
FGFR-1
FLG
FLT-2
HBGFR
bFGF-R-1
EC 2.7.10.1
HH2
HRTFDS
OGD
Pfeiffer Syndrome
CD331
N-SAM
FGFR1/PLAG1 Fusion
Heparin-Binding Growth Factor Receptor
Hydroxyaryl-Protein Kinase
N-sam
CD331 Antigen
EC 2.7.10
NCBI: 8p12    Ensembl: 8p11.22
FGFR1_HUMANSize: 822 amino acidsMass: 91868 Da

  • Subunit: Monomer. Homodimer after ligand binding. Interacts predominantly with FGF1 and FGF2, but can also interact with FGF3, FGF4, FGF5, FGF6, FGF8, FGF10, FGF19, FGF21, FGF22 and FGF23 (in vitro). Ligand specificity is determined by tissue-specific expression of isoforms, and differences in the third Ig-like domain are crucial for ligand specificity. Affinity for fibroblast growth factors (FGFs) is increased by heparan sulfate glycosaminoglycans that function as coreceptors. Likewise, KLB increases the affinity for FGF19, FGF21 and FGF23. Interacts (phosphorylated on Tyr-766) with PLCG1 (via SH2 domains). Interacts with FRS2. Interacts (via C-terminus) with NEDD4 (via WW3 domain). Interacts with KL (By similarity). Interacts with SHB (via SH2 domain) and GRB10. Interacts with KAL1; this interaction does not interfere with FGF2-binding to FGFR1, but prevents binding of heparin-bound FGF2. Interacts with SOX2 and SOX3 (By similarity) Sequence caution: Sequence=BAD92156.1; Type=Erroneous initiation; Note=Translation N-terminally shortened; Selected PDB 3D structures from [IMAGE] and Proteopedia [IMAGE] for FGFR1 (see all 27): 1AGW (3D) [IMAGE] 1CVS (3D) [IMAGE] 1EVT (3D) [IMAGE] 1FGI (3D) [IMAGE] 1FGK (3D) [IMAGE] 1FQ9 (3D) [IMAGE]
  • Tissue specificity: Detected in astrocytoma, neuroblastoma and adrenal cortex cell lines. Some isoforms are detected in foreskin fibroblast cell lines, however isoform 17, isoform 18 and isoform 19 are not detected in these cells [IMAGE] Pathway & Disease-focused RT2 Profile
  • Function:
    Tyrosine-protein kinase that acts as cell-surface receptor for fibroblast growth factors and plays an essential role in the regulation of embryonic development, cell proliferation, differentiation and migration. Required for normal mesoderm patterning and correct axial organization during embryonic development, normal skeletogenesis and normal development of the gonadotropin-releasing hormone (GnRH) neuronal system. Phosphorylates PLCG1, FRS2, GAB1 and SHB. Ligand binding leads to the activation of several signaling cascades. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate. Phosphorylation of FRS2 triggers recruitment of GRB2, GAB1, PIK3R1 and SOS1, and mediates activation of RAS, MAPK1/ERK2, MAPK3/ERK1 and the MAP kinase signaling pathway, as well as of the AKT1 signaling pathway. Promotes phosphorylation of SHC1, STAT1 and PTPN11/SHP2. In the nucleus, enhances RPS6KA1 and CREB1 activity and contributes to the regulation of transcription. FGFR1 signaling is down-regulated by IL17RD/SEF, and by FGFR1 ubiquitination, internalization and degradation
                          
    Tyrosine-protein kinase that acts as cell-surface receptor for fibroblast growth factors and plays an essential role in the regulation of embryonic development, cell proliferation, differentiation and migration. Required for normal mesoderm patterning and correct axial organization during embryonic development, normal skeletogenesis and normal development of the gonadotropin-releasing hormone (GnRH) neuronal system. Phosphorylates PLCG1, FRS2, GAB1 and SHB. Ligand binding leads to the activation of several signaling cascades. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate. Phosphorylation of FRS2 triggers recruitment of GRB2, GAB1, PIK3R1 and SOS1, and mediates activation of RAS, MAPK1/ERK2, MAPK3/ERK1 and the MAP kinase signaling pathway, as well as of the AKT1 signaling pathway. Promotes phosphorylation of SHC1, STAT1 and PTPN11/SHP2. In the nucleus, enhances RPS6KA1 and CREB1 activity and contributes to the regulation of transcription. FGFR1 signaling is down-regulated by IL17RD/SEF, and by FGFR1 ubiquitination, internalization and degradation
  • Catalytic activity:
    ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate
  • Similarity:
    Belongs to the protein kinase superfamily. Tyr protein kinase family. Fibroblast growth factor receptor subfamily
                          
    Contains 3 Ig-like C2-type (immunoglobulin-like) domains
                          
    Contains 1 protein kinase domain [IMAGE]
  • Protein Domain/Family    
    Source ID Domain Name Type
    InterProIPR000719Prot_kinase_domProtein kinaseDomain
    IPR001245Ser-Thr/Tyr_kinase_cat_domTyrosine protein kinaseDomain
    IPR003598Ig_sub2Immunoglobulin C2 typeDomain
    IPR007110Ig-like_domImmunoglobulin-likeDomain
    IPR008266Tyr_kinase_ASTyrosine protein kinase, active siteActive Sites
    IPR011009Kinase-like_domProtein kinase-likeDomain
    IPR013098Ig_I-setImmunoglobulin I-setDomain
    BlocksIPB003598Immunoglobulin C-2 typeImmunoglobulin C-2 type
    IPB008266Tyrosine protein kinaseTyrosine protein kinase, active site

    Gene Ontology    
    Type Term Evidence Source Pub
    Biological Process cell migration TAS GOA 15863030
    chordate embryonic development TAS GOA 15863030
    fibroblast growth factor receptor signaling pathway IPI GOA 10830168
    fibroblast growth factor receptor signaling pathway IDA GOA 8663044
    fibroblast growth factor receptor signaling pathway IGI GOA 8663044
    MAPK cascade TAS GOA 10748122
    neuron migration TAS GOA 15863030
    peptidyl-tyrosine phosphorylation IDA GOA 18480409
    phosphatidylinositol-mediated signaling TAS GOA 12141425
    positive regulation of cell proliferation IDA GOA 8663044
    positive regulation of cell proliferation IGI GOA 8663044
    positive regulation of cell proliferation IMP GOA 8622701
    positive regulation of MAP kinase activity IDA GOA 18480409
    positive regulation of MAPK cascade IMP GOA 8622701
    positive regulation of neuron differentiation IMP GOA 8622701
    positive regulation of phosphatidylinositol 3-kinase signaling TAS GOA 15863030
    positive regulation of phospholipase activity TAS GOA 12141425
    positive regulation of phospholipase C activity IDA GOA 18480409
    protein autophosphorylation IDA GOA 8622701
    protein phosphorylation NAS GOA 1846977
    regulation of cell differentiation TAS GOA 12141425
    skeletal system development TAS GOA 7874169
    skeletal system morphogenesis TAS GOA 15863030
    Cellular Component extracellular region NAS GOA 1652059
    integral component of membrane NAS GOA 1652059
    integral component of plasma membrane TAS GOA 10918587
    plasma membrane IDA GOA 18480409
    Molecular Function fibroblast growth factor binding IDA GOA 18480409
    fibroblast growth factor-activated receptor activity TAS GOA 2167437
    fibroblast growth factor-activated receptor activity IDA GOA 18480409
    heparin binding IDA GOA 18480409
    identical protein binding IPI GOA 19696444
    protein binding IPI GOA 10464310
    protein tyrosine kinase activity IDA GOA 8622701

    Disorder & Mutation    
    Source Disease
    SWISS-PROTHypogonadotropic hypogonadism 2 with or without anosmia (HH2) [MIM:147950]: A disorder characterized by absent or incomplete sexual maturation by the age of 18 years, in conjunction with low levels of circulating gonadotropins and testosterone and no other abnormalities of the hypothalamic-pituitary axis. In some cases, it is associated with non-reproductive phenotypes, such as anosmia, cleft palate, and sensorineural hearing loss. Anosmia or hyposmia is related to the absence or hypoplasia of the olfactory bulbs and tracts. Hypogonadism is due to deficiency in gonadotropin-releasing hormone and probably results from a failure of embryonic migration of gonadotropin-releasing hormone-synthesizing neurons. In the presence of anosmia, idiopathic hypogonadotropic hypogonadism is referred to as Kallmann syndrome, whereas in the presence of a normal sense of smell, it has been termed normosmic idiopathic hypogonadotropic hypogonadism (nIHH). Note=The disease is caused by mutations affecting distinct genetic loci, including the gene represented in this entry. Some patients carrying mutations in FGFR1 also have a mutation other HH-associated genes including DUSP6, FGF8, FGF17, FLRT3, GNRH1, GNRHR, HS6ST1, IL17RD, KAL1, KISS1R, NSMF, PROKR2, SPRY4 and TACR3 (PubMed:23643382)
    SWISS-PROTPfeiffer syndrome (PS) [MIM:101600]: A syndrome characterized by the association of craniosynostosis, broad and deviated thumbs and big toes, and partial syndactyly of the fingers and toes. Three subtypes are known: mild autosomal dominant form (type 1); cloverleaf skull, elbow ankylosis, early death, sporadic (type 2); craniosynostosis, early demise, sporadic (type 3). Note=The disease is caused by mutations affecting the gene represented in this entry
    SWISS-PROTOsteoglophonic dysplasia (OGD) [MIM:166250]: Characterized by craniosynostosis, prominent supraorbital ridge, and depressed nasal bridge, as well as by rhizomelic dwarfism and nonossifying bone lesions. Inheritance is autosomal dominant. Note=The disease is caused by mutations affecting the gene represented in this entry
    SWISS-PROTTrigonocephaly 1 (TRIGNO1) [MIM:190440]: A keel-shaped deformation of the forehead, caused by premature fusion of the metopic sutures. It results in a triangular shape of the head. Note=The disease is caused by mutations affecting the gene represented in this entry
    SWISS-PROTNote=A chromosomal aberration involving FGFR1 may be a cause of stem cell leukemia lymphoma syndrome (SCLL). Translocation t(8;13)(p11;q12) with ZMYM2. SCLL usually presents as lymphoblastic lymphoma in association with a myeloproliferative disorder, often accompanied by pronounced peripheral eosinophilia and/or prominent eosinophilic infiltrates in the affected bone marrow
    SWISS-PROTNote=A chromosomal aberration involving FGFR1 may be a cause of stem cell myeloproliferative disorder (MPD). Translocation t(6;8)(q27;p11) with FGFR1OP. Insertion ins(12;8)(p11;p11p22) with FGFR1OP2. MPD is characterized by myeloid hyperplasia, eosinophilia and T-cell or B-cell lymphoblastic lymphoma. In general it progresses to acute myeloid leukemia. The fusion proteins FGFR1OP2-FGFR1, FGFR1OP-FGFR1 or FGFR1-FGFR1OP may exhibit constitutive kinase activity and be responsible for the transforming activity

    FGFR1 cross reference    
    PubMed OMIM Entrez Gene NCKU SNP Nucleotide UniProt Genome Data Viewer HomoloGene